Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study

BACKGROUND AND AIMS: COVID-19 mRNA vaccines were approved to prevent severe forms of the disease, but their immunogenicity and safety in cirrhosis is poorly known. METHOD: In this prospective single-center study enrolling patients with cirrhosis undergoing COVID-19 vaccination (BNT162b2 and mRNA-127...

Descripción completa

Detalles Bibliográficos
Autores principales: Iavarone, Massimo, Tosetti, Giulia, Facchetti, Floriana, Topa, Matilde, Er, Joey Ming, Hang, Shou Kit, Licari, Debora, Lombardi, Andrea, D'Ambrosio, Roberta, Degasperi, Elisabetta, Loglio, Alessandro, Oggioni, Chiara, Perbellini, Riccardo, Caccia, Riccardo, Bandera, Alessandra, Gori, Andrea, Ceriotti, Ferruccio, Scudeller, Luigia, Bertoletti, Antonio, Lampertico, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2023
Materias:
Liver, Pancreas and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575378/
https://www.ncbi.nlm.nih.gov/pubmed/36266209
http://dx.doi.org/10.1016/j.dld.2022.09.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575378/
https://www.ncbi.nlm.nih.gov/pubmed/36266209
http://dx.doi.org/10.1016/j.dld.2022.09.010

Ejemplares similares